IDEX has granted the Co-Lead Agents an option (the “Agents Option”) to offer for sale up to an additional 15% in Subscription Units (the “Over-Allotment Option”), exercisable in whole or in part, at ...

I would never want to do a commercial unless I could do it on my own terms, unless it could be genuinely funny and creative.” ...

Accord BioPharma Inc., the U.S. specialty division of Intas Pharmaceuticals Ltd., has reached an exclusive commercialization and license agreement with Bio-Thera Solutions for BAT2506, a biosimilar ...